Literature DB >> 10856321

Interactions between corticosteroids and beta agonists.

D R Taylor1, R J Hancox.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10856321      PMCID： PMC1745801          DOI： 10.1136/thorax.55.7.595

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  86 in total

1.  One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group.

Authors:  A A Verberne; C Frost; R J Roorda; H van der Laag; K F Kerrebijn
Journal:  Am J Respir Crit Care Med       Date:  1997-09       Impact factor: 21.405

2.  A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group.

Authors:  F E Simons
Journal:  N Engl J Med       Date:  1997-12-04       Impact factor: 91.245

3.  Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjects.

Authors:  G M Gauvreau; M Jordana; R M Watson; D W Cockroft; P M O'Byrne
Journal:  Am J Respir Crit Care Med       Date:  1997-12       Impact factor: 21.405

4.  Albuterol does not antagonize the inhibitory effect of dexamethasone on monocyte cytokine release.

Authors:  P M Seldon; D A Stevens; I M Adcock; B J O'Connor; P J Barnes; M A Giembycz
Journal:  Am J Respir Crit Care Med       Date:  1998-03       Impact factor: 21.405

5.  Inhaled flunisolide for acute severe asthma.

Authors:  G Rodrigo; C Rodrigo
Journal:  Am J Respir Crit Care Med       Date:  1998-03       Impact factor: 21.405

6.  Concomitant administration of low-dose prednisolone protects against in vivo beta2-adrenoceptor subsensitivity induced by regular formoterol.

Authors:  K S Tan; L C McFarlane; B J Lipworth
Journal:  Chest       Date:  1998-01       Impact factor: 9.410

7.  Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

Authors:  R A Pauwels; C G Löfdahl; D S Postma; A E Tattersfield; P O'Byrne; P J Barnes; A Ullman
Journal:  N Engl J Med       Date:  1997-11-13       Impact factor: 91.245

8.  Beta-adrenoceptor agonists block corticosteroid inhibition in eosinophils.

Authors:  C P Nielson; N E Hadjokas
Journal:  Am J Respir Crit Care Med       Date:  1998-01       Impact factor: 21.405

9.  Concomitant inhaled corticosteroid resensitises cardiac beta2-adrenoceptors in the presence of long-acting beta2-agonist therapy.

Authors:  I Aziz; L C McFarlane; B J Lipworth
Journal:  Eur J Clin Pharmacol       Date:  1998-07       Impact factor: 2.953

10.  Salmeterol enhances the inhibitory activity of dexamethasone on allergen-induced blood mononuclear cell activation.

Authors:  S Oddera; M Silvestri; R Testi; G A Rossi
Journal:  Respiration       Date:  1998       Impact factor: 3.580
View more
  12 in total

Review 1.  Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma.

Authors:  E H Walters; J A Walters; P W Gibson
Journal:  Cochrane Database Syst Rev       Date:  2002

2.  Dependence of the lymphocyte proliferative response on the endogenous cortisol level and sensitivity to β-adrenergic regulation in vitro in the early period of penetrating eye injury.

Authors:  V A Chereshnev; Ju I Shilov; M V Chereshneva; V V Chuprina; T V Gavrilova
Journal:  Dokl Biol Sci       Date:  2010-10-21

Review 3.  Interactions between corticosteroids and beta2-agonists.

Authors:  Robert J Hancox
Journal:  Clin Rev Allergy Immunol       Date:  2006 Oct-Dec       Impact factor: 8.667

4.  Current Bronchodilator Responsiveness Criteria Underestimate Asthma in Older Adults.

Authors:  Rodrigo S Cavallazzi; Barbara J Polivka; Bryan L Beatty; Demetra E Antimisiaris; Rangaraj K Gopalraj; Rachel A Vickers-Smith; Rodney J Folz
Journal:  Respir Care       Date:  2020-02-18       Impact factor: 2.258

Review 5.  Inhaled budesonide/formoterol combination.

Authors:  J K McGavin; K L Goa; B Jarvis
Journal:  Drugs       Date:  2001       Impact factor: 9.546

6.  Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma.

Authors:  J G Koopmans; R Lutter; H M Jansen; J S van der Zee
Journal:  Thorax       Date:  2006-01-31       Impact factor: 9.139

7.  Budesonide/glycopyrronium/formoterol fumarate triple therapy prevents pulmonary hypertension in a COPD mouse model via NFκB inactivation.

Authors:  Ratoe Suraya; Tatsuya Nagano; Gusty Rizky Teguh Ryanto; Wiwin Is Effendi; Daisuke Hazama; Naoko Katsurada; Masatsugu Yamamoto; Motoko Tachihara; Noriaki Emoto; Yoshihiro Nishimura; Kazuyuki Kobayashi
Journal:  Respir Res       Date:  2022-06-27

Review 8.  Budesonide/formoterol: in chronic obstructive pulmonary disease.

Authors:  Neil A Reynolds; Caroline M Perry; Gillian M Keating
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  A pilot study of polymorphism of adrenergic Beta-2 receptor and mild asthma: a clinical and pharmacogenetic study.

Authors:  Parisa Adimi Naghan; Fanak Fahimi; Seyed Alireza Nadji; Nima Naderi; Fatemeh Soleimani; Mohammad Reza Masjedi
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

10.  Protective Effects of Clenbuterol against Dexamethasone-Induced Masseter Muscle Atrophy and Myosin Heavy Chain Transition.

Authors:  Daisuke Umeki; Yoshiki Ohnuki; Yasumasa Mototani; Kouichi Shiozawa; Kenji Suita; Takayuki Fujita; Yoshiki Nakamura; Yasutake Saeki; Satoshi Okumura
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.